ITGA6 is strongly expressed in most acute lymphoblastic leukemia patients, and its interaction with laminin enhances the development of CNS disease [5,59,94,118,119] and the maintenance of minimal residual disease (MRD) after chemotherapy [15]. The gene discussed is LAMB2; the disease is acute lymphoblastic leukemia.